Breast Cancer

Showing NaN - NaN of 177

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Jonesboro, Arkansas
  • +142 more
Oct 31, 2023

Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Breast Cancer
  • Neratinib Oral Tablet
  • Ruxolitinib Oral Tablet
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023

Breast Cancer Trial in United States (Placebo, GLSI-100)

Recruiting
  • Breast Cancer
  • Placebo
  • GLSI-100
  • Birmingham, Alabama
  • +21 more
Jan 30, 2023

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Los Alamitos, California
  • +6 more
Jan 25, 2023

Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +228 more
Jan 10, 2023

Breast Cancer Trial in Dallas (Digital Mammography, Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml)

Active, not recruiting
  • Breast Cancer
  • Digital Mammography
  • Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 2, 2023

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Breast Cancer Trial in Dallas

Enrolling by invitation
  • Breast Cancer
    • Dallas, Texas
      Susan G. Komen
    Dec 8, 2022

    NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

    Completed
    • Non-small Cell Lung Cancer
    • +9 more
    • Little Rock, Arkansas
    • +32 more
    Dec 12, 2022

    Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)

    Recruiting
    • Breast Cancer
    • +3 more
    • SV-BR-1-GM
    • +3 more
    • Newport Beach, California
    • +9 more
    Dec 8, 2022

    Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)

    Recruiting
    • Breast Cancer
    • MammaPrint, BluePrint, and Full-Genome Testing
    • Birmingham, Alabama
    • +117 more
    Dec 1, 2022

    Breast Cancer Trial in Dallas (Radiomics on MRI)

    Recruiting
    • Breast Cancer
    • Radiomics on MRI
    • Dallas, Texas
      University of Texas Southwestern Medical Center - Dallas
    Nov 28, 2022

    Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

    Recruiting
    • Breast Neoplasms
    • +10 more
    • Standard Therapy
    • +32 more
    • Birmingham, Alabama
    • +35 more
    Nov 17, 2022

    Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

    Active, not recruiting
    • Breast Cancer
    • Gilbert, Arizona
    • +93 more
    Nov 10, 2022

    Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

    Recruiting
    • Advanced Solid Tumor
    • +7 more
    • PY159 Single agent dose level 1
    • +17 more
    • San Francisco, California
    • +11 more
    Nov 3, 2022

    TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

    Active, not recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Breast Cancer
    • Birmingham, Alabama
    • +111 more
    Oct 25, 2022

    Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Breast Cancer
    • Boston, Massachusetts
    • +2 more
    Oct 21, 2022

    Breast Cancer Trial in Worldwide (DS-8201a)

    Active, not recruiting
    • Breast Cancer
    • Anchorage, Alaska
    • +98 more
    Oct 17, 2022

    Breast Cancer Trial in United States (Selene)

    Recruiting
    • Breast Cancer
    • Selene
    • Tampa, Florida
    • +7 more
    Oct 12, 2022

    Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • New Haven, Connecticut
    • +6 more
    Oct 10, 2022

    Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

    Terminated
    • Glioma
    • +23 more
    • Tucson, Arizona
    • +11 more
    Sep 30, 2022

    Breast Cancer Trial in Dallas (Letrozole, Abemaciclib)

    Recruiting
    • Breast Cancer
    • Dallas, Texas
    • +1 more
    Sep 30, 2022

    Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

    Recruiting
    • Breast Cancer
    • Los Angeles, California
    • +2 more
    Sep 27, 2022

    Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Gilbert, Arizona
    • +16 more
    Sep 13, 2022